Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Dermata Therapeutics Inc. Common Stock
DRMA | US
1.46
USD0.25
20.66%
DRMA | US
About Dermata Therapeutics Inc. Common Stock
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
20/03/2026
Close
1.46
Open
1.50
High
1.84
Low
1.37
Dermata Therapeutics Inc. a clinical-stage medical dermatology company focuses on identifying developing and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. The company's lead product candidate is DMT310 which has completed Phase IIb clinical trial for treatment of moderate-to-severe acne; and Phase Ib proof of concept (POC) trial for Mild-to-Moderate Psoriasis as well as is in a Phase 2 clinical trial for treatment of moderate-to-severe rosacea. It is also developing DMT410 that has completed Phase Ib POC trials for the treatment of hyperhidrosis and aesthetic conditions. Dermata Therapeutics Inc. was incorporated in 2014 and is headquartered in San Diego California.
View LessDRMA | US
Risk
217.0
Sharpe
-0.76
Luna's Score
52/100
Recommendation
Hold
Luna says (DRMA | US)
What's Working
Strength based on increasing price with high volume
High Current Volume and Positive 1-Day Return
Low Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
What's not Working
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
115.0%1 month
217.0%3 months
199.7%6 months
154.7%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.73
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
0.58
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-7.86M
MarketCap
2.20M
MarketCap(USD)
2.20M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-173.01
Short ratio
0.05
Short perc.
4.63
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.68
Range1M
1.18
Range3M
3.55
Volumes: Market Activity
Rel. volume
11.06
Price X volume
56.77M
